Shares of Sun Pharmaceutical Industries extended rally on Monday and soared over 4 per cent on the Bombay Stock Exchange amid strong volume after media reports suggested that the US Food and Drug Administration (USFDA) may start inspection of its facility at Halol in the second week of February. According to data available with exchange, as much as 28.04 lakh shares have changed hand over the counter as compared to two-week average of 6.08 lakh shares. Boosted by volume trade, shares of the company gained as much 4.44 per cent and touched an intra-day high of Rs 604.50 apiece on the Bombay Stock Exchange.
In a similar fashion, shares of the firm were trading 2.83 per cent higher at Rs 595.15 apiece on the National Stock Exchange. Meanwhile, the broader benchmark BSE Sensex was trading at 34,354.51, up 200.56 points, or 0.59 per cent, at 12:45 hours.